Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing medical applications of CBD
3.2.1.2 Growing preference for CBD over conventional pharmaceuticals
3.2.1.3 Changing regulatory landscape for approval of CBD products
3.2.1.4 Increasing sales of CBD products in retail stores
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects associated with CBD oil
3.2.2.2 Counterfeit and synthetic products available in the market
3.2.2.3 Regulatory uncertainties
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Source, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Hemp
5.3 Marijuana
Chapter 6 Market Estimates and Forecast, By Product Type, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Original
6.3 Blended
Chapter 7 Market Estimates and Forecast, By Product Category, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Flavoured CBD oil
7.3 Unflavoured CBD oil
Chapter 8 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Nutraceuticals
8.3 Pharmaceuticals
8.3.1 Pain management
8.3.2 Anxiety and depression
8.3.3 Sleep disorder
8.3.4 Skin care
8.3.5 Neurological disorders
8.3.6 Other pharmaceutical applications
Chapter 9 Market Estimates and Forecast, By Formulation, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Pills & capsules
9.3 Creams & roll-ons
9.4 Transdermal patches
9.5 Drops
9.6 Other formulations
Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Million)
10.1 Key trends
10.2 Online
10.3 Offline
10.3.1 Hospital pharmacy
10.3.2 Retail stores
Chapter 11 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
11.1 Key trends, by region
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 Aurora Cannabis Inc
12.2 Bluebird Botanicals
12.3 BIOTA Biosciences
12.4 CHARLOTTE’S WEB
12.5 Elixinol
12.6 Endoca
12.7 Evora Worldwide
12.8 Green Roads
12.9 Hempstrol
12.10 Health Horizons
12.11 Medical Mary, LLC
12.12 Medterra CBD
12.13 Neurogan
